Vivo Capital Fund IX, L.P.'s Net Worth
$452 Million
Who is Vivo Capital Fund IX, L.P.?
Vivo Capital Fund IX, L.P. has an estimated net worth of $452 Million. This is based on reported shares across multiple companies, which include Instil Bio, Inc., Tarsus Pharmaceuticals, Inc., ALX ONCOLOGY HOLDINGS INC, IO Biotech, Inc., and Sierra Oncology, Inc..
SEC CIK
Vivo Capital Fund IX, L.P.'s CIK is 0001750117
Past Insider Trading and Trends
2020 was Vivo Capital Fund IX, L.P.'s most active year for acquiring shares with 9 total transactions. Vivo Capital Fund IX, L.P.'s most active month to acquire stocks was the month of December. 2022 was Vivo Capital Fund IX, L.P.'s most active year for disposing of shares, totalling 13 transactions. Vivo Capital Fund IX, L.P.'s most active month to dispose stocks was the month of June. 2022 saw Vivo Capital Fund IX, L.P. paying a total of $29,684,168.40 for 1,412,437 shares, this is the most they've acquired in one year. In 2022 Vivo Capital Fund IX, L.P. cashed out on 7,559,588 shares for a total of $214,552,826.06, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sierra Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.33M |
$55.00 | -$183,123,160.00 |
0
|
Jul 1
| |||
Form 4
| +41.33% | 800K |
$27.00 | $21,600,000.00 | 2.74M |
Jan 31
| |||
Form 4
| +31.95% | 612.44K |
$13.20 | $8,084,168.40 | 2.53M |
Jan 26
| |||
Form 4
| +3,045.01% | 1.86M |
—
|
—
| 1.92M |
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $15.045
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.22M |
$19.00 | $3,524,994.00 | 4.22M |
Jul 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IO Biotech, Inc. (IOBT) Snapshot price: $1.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.16M |
$1.90 | $5,999,998.60 | 3.16M |
Aug 9
| |||
Form 4
|
∞
| 3.02M |
$14.00 |
—
| 3.02M |
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Instil Bio, Inc. (TIL) Snapshot price: $11.5599
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 12.49M |
$20.00 |
—
| 12.49M |
Mar 23
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tarsus Pharmaceuticals, Inc. (TARS) Snapshot price: $29.64
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.22% | -5.37K |
$12.25 | -$65,831.50 | 2.47M |
May 5
| |||
Form 4
| -17.17% | -512.96K |
$13.39 | -$6,866,310.96 | 2.47M |
May 2 - May 4
| |||
Form 4
| -1.83% | -55.68K |
$29.79 | -$1,658,842.40 | 2.99M |
Jun 23 - Jun 25
| |||
Form 4
| -6.21% | -201.62K |
$29.05 | -$5,856,114.00 | 3.04M |
Jun 21 - Jun 22
| |||
Form 4
| -0.01% | -400.00 |
$30.37 | -$12,148.00 | 3.24M |
Apr 14
| |||
Form 4
|
∞
| 3.25M |
$16.00 |
—
| 3.25M |
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||